Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
30.8M
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
2.76M
-
Shares change
-
-298K
-
Total reported value, excl. options
-
$9.67M
-
Value change
-
-$1.05M
-
Number of buys
-
8
-
Number of sells
-
-21
-
Price
-
$3.51
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q4 2022
43 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q4 2022.
XBiotech Inc. - Common Shares, no par value (XBIT) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.76M shares
of 30.8M outstanding shares and own 8.96% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (854K shares), BlackRock Inc. (261K shares), CREDIT SUISSE AG/ (245K shares), GEODE CAPITAL MANAGEMENT, LLC (155K shares), Oasis Management Co Ltd. (137K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (123K shares), RENAISSANCE TECHNOLOGIES LLC (101K shares), MORGAN STANLEY (98.4K shares), DIMENSIONAL FUND ADVISORS LP (82.4K shares), and TWO SIGMA INVESTMENTS, LP (66K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.